老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cue Biopharma, Inc.

33.50
+1.865.86%
成交量：2.61萬
成交額：83.96萬
市值：2.43億
市盈率：-1.14
高：33.50
開：31.27
低：30.33
收：31.64
52周最高：45.50
52周最低：4.97
股本：726.44萬
流通股本：684.53萬
量比：0.79
換手率：0.38%
股息：- -
股息率：- -
每股收益(TTM):-29.4600
每股收益(LYR):-8.4244
淨資產收益率：-1603.48%
總資產收益率：-172.66%
市淨率：105.33
市盈率(LYR):-3.98

資料載入中...

總覽公司新聞資訊公告
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/19

重要事件披露

8-K - Current report
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/09/17

重要事件披露

8-K - Current report
2020/08/24

重要事件披露

8-K - Current report
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/15

重要事件披露

8-K - Current report
2020/06/26

重要事件披露

8-K - Current report
2020/06/22

重要事件披露

8-K - Current report
2020/06/05

重要事件披露

8-K - Current report
2020/05/19

重要事件披露

8-K - Current report
2020/05/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/04/29

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/04/21

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/27

重要事件披露

8-K - Current report
2020/03/17

重要事件披露

Current report, items 2.02 and 9.01
2020/03/12

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/12

[修訂]年度報告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
更多